CN Bio, which provides Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, ...

Pioneering biotech Maxion Therapeutics has more than doubled its footprint at Howard Group's Unity Campus in Cambridge.

Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...

A superchip superstar has taken the CEO role at the exciting Cambridge open silicon ecosystem organisation lowRISC C.I.C. Javier Orensanz Martinez takes the reins on June 2 with more than two decades ...

Type 1 diabetes sufferers in the UK and certain other locations in Europe can now manage their condition directly from the iPhone thanks to Cambridge innovation. University of Cambridge spin-out ...

Cambridge life science game-changer ViaNautis has long caught the eye as one of the sector's most exciting companies and ...

Carbon13 in Cambridge has struck a fresh blow for ClimateTech by investing £1.2 million into an exciting array of sustainable ...

Cambridge life science company CellCentric has raised $120 million Series C financing to advance its fight against an ...

Arecor Therapeutics plc, an AIM-quoted life science company based in Cambridge, has agreed a significant formulation ...

Wooing next generation talent is a keynote feature of Cambridge Tech Week in September. CTW's Tech Futures initiative is ...

Ventures Tour featuring a range of portfolio pitch sessions hosted by some of Cambridge’s most prominent venture capital ...

Vellos – a company founded by the Director of the Milner Therapeutics Institute at the University of Cambridge , Professor Sir Tony Kouzarides – has announced a new partnership with Fifty Years, a ...